- Damon Runyon Fellowship Award
- Damon Runyon-Sohn Pediatric Fellowship Award *NEW*
- Damon Runyon Clinical Investigator Award
- Damon Runyon-Rachleff Innovation Award
Innovators
(Three-year Awards)
2011 Recipients
Alexei A. Aravin, PhD
“Epigenetic regulation of transposable elements in cancer” California Institute of Technology, Pasadena, California
James E. Bradner, PhD
“Targeting epigenetic readers as cancer therapy” Dana-Farber Cancer Institute, Boston, Massachusetts
Joshua E. Elias, PhD
“How cancers cope with damage: a proteomics approach” Stanford University School of Medicine, Stanford, California
Benjamin P. Tu, PhD
“A novel strategy for attacking tumors based on the identification of a fundamental carbon-source signal driving cell growth” University of Texas Southwestern Medical Center, Dallas, Texas
Matthew G. Vander Heiden, MD, PhD
“Understanding the metabolic requirements of cancer cells” Massachusetts Institute of Technology, Cambridge, Massachusetts
2010 Recipients
Heather R. Christofk, PhD
“Regulation of cancer metabolism” University of California, Los Angeles, California
Joshua C. Munger, PhD
“Elucidating mechanisms of oncogenic metabolic manipulation” University of Rochester, Rochester, New York
Raffaella Sordella, PhD
“Characterization of Erlotinib resistant, Mesenchymal and Metastatic (EMM) cells present in naïve lung tumors prior to treatments” Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
2009 Recipients
Ivan Maillard, MD, PhD, (and Yi Zhang, MD, PhD)
“Modulation of Notch signaling to control graft-versus-host-disease and preserve the anti-tumor activity of alloreactive T cells” University of Michigan, Ann Arbor, Michigan
John L. Rinn, PhD
“The functional roles of large intergenic non-coding RNAs in cancer” Beth Israel Deaconess Medical Center, Boston, Massachusetts
Muneesh Tewari, MD, PhD
“Cancer detection in ‘pre-diagnosis’ blood samples via exosome-associated small RNAs” Fred Hutchinson Cancer Research Center, Seattle, Washington
Yi Zhang, MD, PhD, (and Ivan Maillard, MD, PhD)
“Modulation of Notch signaling to control graft-versus-host-disease and preserve the anti-tumor activity of alloreactive T cells” University of Michigan, Ann Arbor, Michigan
2008 Recipients
Nathanael S. Gray, PhD
“Identification of kinase substrates using selective irreversible crosslinkers” Dana-Farber Cancer Institute, Boston, Massachusetts
David G. Kirsch, MD, PhD
“Transforming cancer therapy with molecular imaging” Duke University, Durham, North Carolina
Sarkis K. Mazmanian, PhD
“Host-bacterial immunomodulation in the development of cancer” California Institute of Technology, Pasadena, California

